Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Addition to Benzodiazepines for AWS in ICU
NCT02496650Phase 4Completed
- Start
- Jan 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of dexmedetomidine in alcohol withdrawal syndrome (AWS). Started Jan 2013; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
alcohol withdrawal syndrome (AWS)
Beyond the preview
Go deeper on NCT02496650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02496650.